70
Views
59
CrossRef citations to date
0
Altmetric
Research Article

The contribution of proton magnetic resonance spectroscopy ( 1 HMRS) to clinical brain tumour diagnosis

, , , , , , , & show all
Pages 329-334 | Published online: 06 Jul 2009

  • On D, Hennig J, Ernst T. Human brain tumours: assessment with in vivo proton spectroscopy. Radiology 1993;186(3):745-52.
  • Tien RD, Lai RM, Smith JS, Lazayras R. Single-Voxel Proton Brain Spectroscopy Exam (PROBE/SV) in patients with primary brain tumours. Am J Radial 1996;167:201-9.
  • Preul MC, Caramanos Z, Collins DL, Villemure J, Leblanc R, Olivier A, Pokrupa R, Arnold D. Accurate, noninvasive diagnosis of human brain tumours by using proton magnetic resonance spectroscopy. Nature Med 1996;2(3):323-5.
  • Poptani H, Kaartinen J, Gupta RK, Niemitz M, HiltunenY, Kauppinen RA. Diagnostic assessment of brain tumours and non-neoplastic brain disorders in vivo using proton magnetic resonance spectroscopyand artificial neural networks. J Cancer Res Clin Oncol 1999;125(6):343-9.
  • Usenius JP, Tuohimetsa S, Vainio P, Ala-Korpela M, Hiltunen Y, Kauppinen RA. Automated classification of human brain tumours by neural network analysis using in vivo IH magnetic resonance spectroscopic metabolite phenotypes. Neuroreport 1996;7(10):1597-600.
  • Falini A, Calabrese G, Origgi D, Lipari 5, Triulzi F, Losa M, Scotti G. Proton magnetic resonance spectroscopy and intracranial tumours: clinical perspectives. J Neural 1996;243(10):706-14.
  • Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK. Characterisation of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR 1995;16(8):1593-603.
  • Castillo M. Kwock L, Scatliff J, Mukherji SK. Proton MR spectroscopy in neoplastic and non-neoplastic brain disorders. Mag Res Imag Clin N Am 1998; 6(1):1-20.
  • Harada M, Tanouchi M. Nishitani H, Miyoshi, Bandou K, Kannuki S. Noninvasive characterisation of brain tumour by in-vivo proton magnetic resonance spectroscopy. Jpn J Cancer Res_1995;86(3):329-32.
  • Poptani H, Gupta RK, Jain VK, Roy R, Pandey R. Cystic intracranial mass lesions: possible role of in vivo MR spectroscopy in its differential diagnosis. Magn Reson Imaging 1995:13(7):1019-29.
  • Castillo M, Kwock L. Proton MR spectroscopy of common brain tumours. Neuroimaging Clin N Am 1998;8(4):733-52.
  • Tien RD, Lai PH, Smith JS, Lazeyras F. Singlevoxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumours. AJR 1996; 167:201-9.
  • Negendank W. Studies of human tumours by MRS: a review. NMR Biomed 1992;5:303-324.
  • Frahm J. Bruhn H, Hanicke W, Merboldt KD, Mursch K, Markakis E. Localised proton NMR spectroscopy of brain tumours using short-echo time STEAM sequences. J Comput Assist Tomogr 1991;15:915-22.
  • Ott D, Hennig J, Ernst T. Human brain tumours: assessment with in vivo proton MR spectroscopy. Radiology 1993;186:745-52.
  • Preul MC, Caramanos Z, Collins DL et al. Accurate, noninvasive diagnosis of human brain tumours by using proton magnetic resonance spectroscopy. Nature Med 1996;2:323-5.
  • Tate AR, Griffiths JR, Martinez-Perez I, et al. Towards a method for automated classification of 1H MRS spectra from brain tumours. NMR Biomed 1998; 11(4-5):177-91.
  • Henriksen O. In vivo quantisation of metabolite concentrations in the brain by means of proton MRS. NMR Biomed_1995;8(4):139-48.
  • Florian CL, Preece NE, Bhakoo KK, Williams SR, Noble M. Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours. NMR Biomed 1995;8(6):253-64.
  • Barton SJ, Howe FA, Tomlins AM, Cudlip SA, Nicholson JK, Griffiths JR. Comparison of in vivo 1H MRS of human brain tumours with IH-MAS spectroscopy of intact samples in vitro. Magma 1999; 8(2): 121-8.
  • Robinson SP, Barton SJ, McSheehy PM, Griffiths JR. Nuclear magnetic resonance spectroscopy of cancer. Magma 1997,70:60-9.
  • Manton DJ, Lowry M, Rowland-Hill C, Crooks D, Mathew B, Turnbull LW. Combined proton MR spectroscopy and dynamic contrast enhanced MR imaging of human intracranial tumours in vivo NMR Biomed 2000,13:449-59.
  • Heesters MA, Kamman RL, Mooyaart EL, Go KG. Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy. J Neurooncol 1993;17(l):27-35.
  • Tate AR, Griffiths JR, Martinez-Perez I, et al. Towards a method for automated classification of IH MRS spectra from brain tumours. NMR Biomed 1998; 11(4-5)177-91.
  • Lara RS, Maison GB, Hugg JW, Maudsley AA, Weiner MW. Quantitation of in vivo phosphorus metabolites in human brain with magnetic resonance spectroscopic imaging (MRSI). Mag Res Imaging 1993;11:273-8.
  • Kreis E, Ross BD. Absolute quantitation of water and metabolites in the human brain. J Magnet Res 1993; 102:1-8.
  • Zulch KJ. Histological typing of tumours of the central nervous system. Geneva: World Health Organization, 1979.
  • Pouwels PJW, Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localised proton MRS. Magnet Reson Med 1998; 39:53-60.
  • Cabello JR, Cohen J. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed 1992; 5:226-33.
  • Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR, Di Chiro G. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 1997;87: 516-24.
  • Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE. Automated single-voxel proton MRS:technical development and multisite verification. Magnet Reson Med 1994;31:365-72.
  • Vanhamme L, Van den Boogart A, van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magnet Reson Imag 1997;29:35-43.
  • Saunders DE, Howe FA, van den Boogart A, Griffiths JR, Brown NM. Ageing of the adult human brain: in vivo quantification of metabolite content with proton magnetic resonance spectroscopy. J Magn Reson Imag 1998;9:711-16.
  • Earnest F, Kelly PJ, Scheithauer BW, Kail BA, Cascino TL, Ehman RL, Forbes GS, Axley PL. Cerebral astrocytomas: Histopathologic correlation of MR and CT contrast enhancement with stereotaxic biopsy. Radiology 1988;166:823-7.
  • Daumas-Duport C, Scheithauer B, Kelly P. A histologie and cytologie method for the spatial definition of gliomas. Mayo CKn Proc 1987;62:435.
  • Paulus W, Peiffer J. Intratumoral histologie heterogeneity of gliomas. Cancer 1989;64:442-7.
  • Yu X, Liu Z,Tian Z, Huang H, Xiu B, Zhao Q, Liu L, Jing W. Stereotactic biopsy for intracranial spaceoccupying lesions. Stereotact Funct Neurosurg 2000; 75(2-3):103-8.
  • Schlemmer HP, Bachert P, Herferth KK, Zuna I, Debus J, van Kaick. Proton MR spectroscopic evaluation of suspicious brain lesions after Stereotactic radiotherapy. AJNR 2001;22(7):1316-24.
  • Underwood J, Tate AR, Luckin R, Majos C, Capdevila A, Howe F, Griffiths J, Arus C. A prototype decision support system for MR spectroscopy-assisted diagnosis of brain tumours. Meatnfo 2001;10(Pt 1):561-5.
  • Kondziolka D, Lunsford LD, Martinez AJ. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supra tentorial (low-grade) astrocytoma. J Neurosurg 1993;79:533-6.
  • Tate AR, Julià-Sapé M, Ladroue C, et al. Automated classification of brain tumours from 1HMRS spectra in INTERPRET, a multi-centre collaboration, ISMRM 1OA Meeting, Hawaii, 18-24 May 2002, oral presentation.
  • Howe FA, Barton SJ, Cudlip SA et al. Metabolic profiles of human brain tumours using quantitative in vivo 1H magnetic resonance spectroscopy. Accepted by Magnetic Resonance in Medicine 15/08/2002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.